Page last updated: 2024-12-08

valtrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

valtrate: Baldrisedon contains 100mg extract of Radix Valerianae mexicanae which contains 50mg valepotriate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	442436
CHEMBL ID	402061
CHEBI ID	9928
SCHEMBL ID	1073699
MeSH ID	M0095590

Synonyms (48)

Synonym
ACON0_000478
valtrate [inn]
butanoic acid, 3-methyl-, 4-((acetyloxy)methyl)-6,7a-dihydrospiro(cyclopenta(c)pyran-7(1h),2'-oxirane)-1,6-diyl ester, (1s-(1-alpha,6-alpha,7-beta,7a-alpha))-
valtrato [inn-spanish]
valtratum [inn-latin]
4-acetoxymethyl-1,6,7,7a-tetrahydro-1,6-bis(isovaleryloxy)cyclopenta(c)pyran-7-spiro-2'-oxiran
3a,4-dihydro-3,4-dihydroxyspiro(benzofuran-2(3h),2'-oxirane)-6-methanol 6-acetate 3,4-diisovalerate
1,7a-dihydro-1,6-dihydroxyspiro(cyclopenta(c)pyran-7-(6h),2'-oxirane)-4-methanol 4-acetate 1,6-diisovalerate
ccris 5795
einecs 242-174-2
valtrats [german]
(7s)-4-acetoxymethyl-1,6,7,7a-tetrahydro-1alpha,6alpha-bis(isovaleroyl)cyclopent(c)pyran-7-spiro-2-oxiran
baldrisedon
halazuchrome b
valepotriate
MEGXP0_000900
C09801
valtratum
18296-44-1
valtrate
LMPR0102070015
[(1s,6s,7r,7as)-4-(acetoxymethyl)-1-(3-methylbutanoyloxy)spiro[6,7a-dihydro-1h-cyclopenta[c]pyran-7,2'-oxirane]-6-yl] 3-methylbutanoate
(1s,6s,7r,7as)-4-[(acetyloxy)methyl]-6,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-oxirane]-1,6-diyl bis(3-methylbutanoate)
[(1s,6s,7r,7as)-4-(acetyloxymethyl)-1-(3-methylbutanoyloxy)spiro[6,7a-dihydro-1h-cyclopenta[c]pyran-7,2'-oxirane]-6-yl] 3-methylbutanoate
unii-l3jq035x9b
valtrats
l3jq035x9b ,
valtrato
chebi:9928 ,
CHEMBL402061
AKOS015896850
SCHEMBL1073699
butanoic acid, 3-methyl-, 4-((acetyloxy)methyl)-6,7a-dihydrospiro(cyclopenta-(c)pyran-7(1h),2'-oxirane)-1,6-diyl ester, (1s-(1-.alpha.,6-.alpha,,7- .beta.,7a-.alpha.))-
valtrate [mart.]
valtrate [who-dd]
V-2700
AC-34887
(1s,2'r,6s)-4-(acetoxymethyl)-6,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-oxirane]-1,6-diyl bis(3-methylbutanoate)
HY-N0718
mfcd00868024
Q27108520
BDIAUFOIMFAIPU-KVJIRVJXSA-N
CS-0009735
MS-27416
butanoic acid, 3-methyl-, 1,1'-[(1s,2'r,6s,7as)-4-[(acetyloxy)methyl]-6,7a-dihydrospiro[cyclopenta[c]pyran-7(1h),2'-oxirane]-1,6-diyl] ester
DTXSID501031053
valtrate (mart.)
butanoic acid, 3-methyl-, 4-((acetyloxy)methyl)-6,7a-dihydrospiro(cyclopenta-(c)pyran-7(1h),2'-oxirane)-1,6-diyl ester, (1s-(1-alpha,6-.alpha,,7-beta,7a-alpha))-

Research Excerpts

Overview

Valtrate is a novel epoxy iridoid ester isolated from Chinese herbal medicine Valeriana jatamansi Jones. It has anti-proliferative activity against various human cancer cell lines.

Excerpt	Reference	Relevance
"Valtrate is a novel epoxy iridoid ester isolated from Chinese herbal medicine Valeriana jatamansi Jones with anti-proliferative activity against various human cancer cell lines. "	( Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling. Chen, L; Cheng, G; Cheng, X; Feng, D; Gu, M; Liu, Q; Lv, H; Qian, Y; Song, H; Wu, Y; Yang, B; Zhang, X, 2021)	3.51

Toxicity

Excerpt	Reference	Relevance
" Compounds with free SH groups like cysteine, mercaptoethanol, dithioerythritol, and glutathione were able to suppress the cytotoxicity of the valepotriates in a dose-dependent way, whereas compounds with blocked SH groups did not antagonize these toxic effects."	( Effects of thiol compounds versus the cytotoxicity of valepotriates on cultured hepatoma cells. Anton, R; Beck, JP; Haag-Berrurier, M; Keochanthala-Bounthanh, C, 1990)	0.28

Pharmacokinetics

Excerpt	Reference	Relevance
" The method was successfully applied to pharmacokinetic studies of valtrate in rats."	( Development of a LC-MS-MS Method for Quantification of Valtrate and Its Application to Pharmacokinetic Study. Lin, W; Qiu, J; Sun, L; Wang, G; Zhang, N, 2015)	0.9

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

Class	Description
fatty acid ester	A carboxylic ester in which the carboxylic acid component can be any fatty acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (8)

Assay ID	Title	Year	Journal	Article
AID423380	Cytotoxicity against human HCT8 cells after 24 hrs by MTT assay	2009	Journal of natural products, Apr, Volume: 72, Issue:4	Acylated iridoids with cytotoxicity from Valeriana jatamansi.
AID104474	Antiviral activity was determined by measurement of HIV-p24 antigen production in the supernatants of the infected MT-4 cell cultures with acommercially available HIV-antigen kit.	2002	Bioorganic & medicinal chemistry letters, Oct-21, Volume: 12, Issue:20	New Rev-transport inhibitor with anti-HIV activity from Valerianae Radix.
AID312045	Cytotoxicity against human PC3M cells by MTT assay	2007	Journal of natural products, Dec, Volume: 70, Issue:12	Sorbifolivaltrates A-D, diene valepotriates from Valeriana sorbifolia(1).
AID423379	Cytotoxicity against human A549 cells after 24 hrs by MTT assay	2009	Journal of natural products, Apr, Volume: 72, Issue:4	Acylated iridoids with cytotoxicity from Valeriana jatamansi.
AID423381	Cytotoxicity against human Bel7402 cells after 24 hrs by MTT assay	2009	Journal of natural products, Apr, Volume: 72, Issue:4	Acylated iridoids with cytotoxicity from Valeriana jatamansi.
AID499280	Inhibition of hemagglutininin-tagged HIV1 Rev protein nuclear export in human HeLa cells assessed as localization by indirect fluorescent antibody technique	2010	Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16	Concise synthesis of 5,6-dihydrovaltrate leading to enhanced Rev-export inhibitory congener.
AID423382	Cytotoxicity against human PC3M cells after 24 hrs by MTT assay	2009	Journal of natural products, Apr, Volume: 72, Issue:4	Acylated iridoids with cytotoxicity from Valeriana jatamansi.
AID475316	Inhibition of hemagglutininin-tagged HIV1 Rev protein nuclear export in human HeLa cells assessed as protein localization after 12 hrs by indirect fluorescent antibody technique	2010	Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7	Bioisostere of valtrate, anti-HIV principle by inhibition for nuclear export of Rev.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	1 (4.35)	18.7374
1990's	3 (13.04)	18.2507
2000's	8 (34.78)	29.6817
2010's	6 (26.09)	24.3611
2020's	5 (21.74)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	30.20 (24.57)
Research Supply Index	3.30 (2.92)
Research Growth Index	5.14 (4.65)
Search Engine Demand Index	36.71 (26.88)
Search Engine Supply Index	2.00 (0.95)

This Compound (30.20)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	1 (4.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	1 (4.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	23 (92.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
indoleacetic acid indoleacetic acid: RN given refers to unlabeled parent cpd; structure in Merck Index, 9th ed, #4841. auxin : Any of a group of compounds, both naturally occurring and synthetic, that induce cell elongation in plant stems (from Greek alphaupsilonxialphanuomega, "to grow").. indole-3-acetic acid : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens has been replaced by a 1H-indol-3-yl group.	2.02	1	0	indole-3-acetic acids; monocarboxylic acid	auxin; human metabolite; mouse metabolite; plant hormone; plant metabolite
diazepam Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.. diazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5.	1.98	1	0	1,4-benzodiazepinone; organochlorine compound	anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic
hypericin [no description available]	2.6	1	0
linalool linalool: RN given refers to parent cpd without isomeric designation; structure. linalool : A monoterpenoid that is octa-1,6-diene substituted by methyl groups at positions 3 and 7 and a hydroxy group at position 3. It has been isolated from plants like Ocimum canum.	2.6	1	0	monoterpenoid; tertiary alcohol	antimicrobial agent; fragrance; plant metabolite; volatile oil component
1-naphthaleneacetic acid 1-naphthaleneacetic acid: a plant growth regulator; RN given refers to parent cpd. naphthylacetic acid : A monocarboxylic acid that is naphthalene substituted by a carboxymethyl group at any position.. 1-naphthaleneacetic acid : A naphthylacetic acid substituted by a carboxymethyl group at position 1.	2.02	1	0	naphthylacetic acid	synthetic auxin
n-pentanoic acid n-pentanoic acid: RN given refers to unlabeled parent cpd. valeric acid : A straight-chain saturated fatty acid containing five carbon atoms.	2.01	1	0	short-chain fatty acid; straight-chain saturated fatty acid	plant metabolite
indolebutyric acid indolebutyric acid: RN given refers to parent cpd. indole-3-butyric acid : A indol-3-yl carboxylic acid that is butanoic acid carrying a 1H-indol-3-yl substituent at position 1.	2.02	1	0	indol-3-yl carboxylic acid	auxin; plant hormone; plant metabolite
paclitaxel Taxus: Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL).	2.05	1	0	taxane diterpenoid; tetracyclic diterpenoid	antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent
didrovaltrate didrovaltrate: RN given refers to (1S-(1alpha,4aalpha,6alpha,7beta,7aalpha))-isomer	3.1	5	0	iridoid monoterpenoid
acevaltrate acevaltrate: RN given for (1S-(1alpha,6alpha,7beta,7aalpha))-isomer	3.42	7	0	fatty acid ester
biotin vitamin B7 : Any member of a group of vitamers that belong to the chemical structural class called biotins that exhibit biological activity against vitamin B7 deficiency. Vitamin B7 deficiency is very rare in individuals who take a normal balanced diet. Foods rich in biotin are egg yolk, liver, cereals, vegetables (spinach, mushrooms) and rice. Symptoms associated with vitamin B7 deficiency include thinning hair, scaly skin rashes around eyes, nose and mouth, and brittle nails. The vitamers include biotin and its ionized and salt forms.	2.01	1	0	biotins; vitamin B7	coenzyme; cofactor; Escherichia coli metabolite; fundamental metabolite; human metabolite; mouse metabolite; nutraceutical; prosthetic group; Saccharomyces cerevisiae metabolite
leptomycin b [no description available]	2.01	1	0
hyperforin hyperforin: a prenylated acylphloroglucinol derivative; antibiotic component of novoimanine; psychoactive agent in St. John's wort; Russian; structure;. hyperforin : A cyclic terpene ketone that is a prenylated carbobicyclic acylphloroglucinol derivative produced by St. John's Wort, Hypericum perforatum.	2.6	1	0
iridoids Iridoids: A type of MONOTERPENES, derived from geraniol. They have the general form of cyclopentanopyran, but in some cases, one of the rings is broken as in the case of secoiridoid. They are different from the similarly named iridals (TRITERPENES).	5.77	20	1
valmane valtrates (combination): from Valerianaceae species; combination of valtratum, acevaltratum & didrovaltratum; structure (valtratum)	2.72	3	0
callystatin a callystatin A: structure in first source	2.01	1	0	diterpenoid
valerenic acid valerenic acid: a saturated oplopanone type indene from Valeriana officinalis. valerenic acid : A monocarboxylic acid that is 2-methylprop-2-enoic acid which is substituted at position 3 by a 3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl group. A bicyclic sesquiterpenoid constituent of the essential oil of the Valerian plant.	2.6	1	0	carbobicyclic compound; monocarboxylic acid; sesquiterpenoid	GABA modulator; plant metabolite; sedative; volatile oil component

Condition	Relationship Strength	Studies	Trials
HIV Coinfection [description not available]	2.46	2	0
HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).	2.46	2	0
Benign Neoplasms, Brain [description not available]	2.6	1	0
Astrocytoma, Grade IV [description not available]	2.6	1	0
Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.	2.6	1	0
Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.	7.6	1	0
Behavior Disorders [description not available]	2.6	1	0
Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.	2.6	1	0
Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.	2.45	2	0
Cancer of Pancreas [description not available]	2.31	1	0
Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).	2.31	1	0
Breast Cancer [description not available]	2.25	1	0
Breast Neoplasms Tumors or cancer of the human BREAST.	2.25	1	0
Cancer of Ovary [description not available]	2.08	1	0
Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.	2.08	1	0
Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)	2.11	1	0
Cancer of Colon [description not available]	2.15	1	0
Cancer of Prostate [description not available]	2.15	1	0
Colonic Neoplasms Tumors or cancer of the COLON.	2.15	1	0
Prostatic Neoplasms Tumors or cancer of the PROSTATE.	2.15	1	0
Deficiency, Mental [description not available]	3.39	1	1
Long Sleeper Syndrome [description not available]	3.39	1	1
Attention Deficit and Disruptive Behavioral Disorders [description not available]	3.39	1	1
Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)	3.39	1	1
Sleep Wake Disorders Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle.	3.39	1	1
Attention Deficit and Disruptive Behavior Disorders Includes two similar disorders: oppositional defiant disorder and CONDUCT DISORDERS. Symptoms occurring in children with these disorders include: defiance of authority figures, angry outbursts, and other antisocial behaviors.	3.39	1	1
ANS (Autonomic Nervous System) Diseases [description not available]	1.96	1	0
Psychophysiologic Disorders A group of disorders characterized by physical symptoms that are affected by emotional factors and involve a single organ system, usually under AUTONOMIC NERVOUS SYSTEM control. (American Psychiatric Glossary, 1988)	1.96	1	0
Drug Withdrawal Symptoms [description not available]	1.98	1	0
Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.	1.98	1	0

chemdatabank.com